Xencor | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
AbbVie USD 3.32B 2.71B 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Arrowhead Research USD 52.59M 132.85M 2024-12
AstraZeneca USD 40.87B 66M 2024-12
Biogen USD 16.72B 357.1M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Cytokinetics USD -135372000 121.46M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
J&J USD 71.49B 1.33B 2024-12
MacroGenics USD 120.07M 62.25M 2024-09
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Regeneron Pharmaceuticals USD 29.35B 27.7M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
Xencor USD 677.61M 46.22M 2024-12



Xencor Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.